Dec 22 2020: The clonazolam in this tablet was originally undetected. The original sample came in as a quarter of a tablet. Via GC/MS at our lab, nothing besides a weak fentanyl signal was detected. The sender had more of the sample (pulverized at this point) and since they had gotten three positives for benzos with BTNX benzo strips (like BTNX fentanyl test strips, but for benzodiazepines), they sent in the rest of the material to see if the lab could detect a benzo in a different portion of the sample.
Our lab was able to detect clonazolam in the second portion of the tablet after consultation with another Schedule I licensed analytical lab.
The lab is going to go back through the clonazolam tablets we've received in the last year and try different techniques to see if we can learn anything about these strange and disconcerting results.
Partial tablet accepted for testing by prior approval.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our DEA-licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
prior to sending in sample:
BTNX Fentanyl Test Strip: Negative (tested 3x / same result)
BTNX Benzo Test Strip: Positive (tested 3x / same result)
Cross-contamination risk for this sample: High
(see Fentanyl Test Strips, Hot Spots, and Unhomogenized Samples)
Our lab was able to detect clonazolam in the second portion of the tablet after consultation with another Schedule I licensed analytical lab.
The lab is going to go back through the clonazolam tablets we've received in the last year and try different techniques to see if we can learn anything about these strange and disconcerting results.